UWG02CTC also showed higher expression than UWG01CTC of targetable pathways including EGFR, FGFR2, HER-2 (ERBB2), and MET, as well as key genes in the JAK/STAT pathway, genes which overexpression are frequently reported in gastric adenocarcinomas but not gastrointestinal neuroendocrine cancers16,30,31. The gene discussed is FGFR2; the disease is gastric adenocarcinoma.